These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 4946253)
21. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections. Tan TH; Tay L; Yeo M; Feng PH Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995 [No Abstract] [Full Text] [Related]
22. Chemical and biological properties of rifampicin. Furesz S Antibiot Chemother; 1970; 16():316-51. PubMed ID: 5002304 [No Abstract] [Full Text] [Related]
23. The place of cephalosporins in antibacterial treatment of infectious diseases. Neu HC J Antimicrob Chemother; 1980 Sep; 6 Suppl A():1-11. PubMed ID: 6998939 [No Abstract] [Full Text] [Related]
24. [Development of resistance. Problems of chemotherapy in urology]. Engel D Z Arztl Fortbild (Jena); 1977 Sep; 71(18):843-5. PubMed ID: 413268 [No Abstract] [Full Text] [Related]
25. [Rational and economic antibiotics therapy in medical practice and outpatient clinics]. Münch R; Lüthy R Dtsch Med Wochenschr; 1984 May; 109(21):834-40. PubMed ID: 6547090 [No Abstract] [Full Text] [Related]
27. [Models of anaerobic (nonclostridial) infections used for evaluating chemotherapeutic preparations]. Miasnikova LG Antibiot Khimioter; 1989 Apr; 34(4):308-13. PubMed ID: 2751390 [No Abstract] [Full Text] [Related]
28. [Study of the antibacterial action of dimethyl sulfoxide]. Fomin DKh; Tatchin SM; Veselovskaia LI; Alycheva IS Antibiotiki; 1974 Aug; 19(8):745-8. PubMed ID: 4616643 [No Abstract] [Full Text] [Related]
29. [Case studies of bacterial species responsible for urinary tract infections and their sensitivity to antibiotic treatment]. Dominici C; Morozzi B Minerva Chir; 1978 Dec 15-31; 33(23-24):1745-62. PubMed ID: 740260 [TBL] [Abstract][Full Text] [Related]
30. [Quorum sensing and quorum quenching: how to disrupt bacterial communication to inhibit virulence?]. Mion S; Rémy B; Plener L; Chabrière É; Daudé D Med Sci (Paris); 2019 Jan; 35(1):31-38. PubMed ID: 30672458 [TBL] [Abstract][Full Text] [Related]
32. [Comparative evaluation of the effectiveness of antibacterial therapeutic methods and agents in acute intestinal infections (a review of the literature)]. Levitov TA Voen Med Zh; 1976; (5):38-43. PubMed ID: 785810 [No Abstract] [Full Text] [Related]
33. [Antibiotic resistance in urinary tract infections in Sweden 1976]. Burman LG; Holm SE Lakartidningen; 1978 Mar; 75(9):781-5. PubMed ID: 628276 [No Abstract] [Full Text] [Related]
34. Virulence versus resistance. Krasinski KM Bull N Y Acad Med; 1987 Apr; 63(3):237-52. PubMed ID: 3300826 [No Abstract] [Full Text] [Related]
35. Bacterial challenges and evolving antibacterial drug strategy. Watt B; Collee JG Postgrad Med J; 1992 Jan; 68(795):6-21. PubMed ID: 1561196 [No Abstract] [Full Text] [Related]
36. Antimicrobial properties of gentamicin on the skin. Lorenzetti OJ; Wernet TC; Breslauer CM Int J Dermatol; 1984 Oct; 23(8):547-9. PubMed ID: 6238917 [No Abstract] [Full Text] [Related]
37. Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties. Speight TM; Brogden RN; Avery GS Drugs; 1972; 3(1):9-78. PubMed ID: 4559812 [No Abstract] [Full Text] [Related]
38. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use. Brogeden RN; Speight TM; Avery GS Drugs; 1975; 9(2):88-140. PubMed ID: 1126306 [TBL] [Abstract][Full Text] [Related]
39. Current usage of antimicrobial combinations in pediatrics. Klein JO Pediatr Clin North Am; 1974 May; 21(2):443-56. PubMed ID: 4600414 [No Abstract] [Full Text] [Related]
40. Ciprofloxacin in the treatment of urinary tract infections caused by Pseudomonas aeruginosa and multiresistant bacteria. Saavedra S; Ramírez-Ronda CH; Nevárez M Eur J Clin Microbiol; 1986 Apr; 5(2):255-7. PubMed ID: 2941296 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]